Evidence map›Paper›PMID 37668846›Full record

ArticleDiscover oncology2023

MiR-3529-3p from PDGF-BB-induced cancer-associated fibroblast-derived exosomes promotes the malignancy of oral squamous cell carcinoma.

Dingyun You, Yanghao Wang, Jianguo Xu, Rongqiang Yang, Weizhou Wang, Xiaofang Wang, Xue Cao, Yiting Li, Lifu Yu, Weihong Wang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Discover oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Dingyun You *Department of Dental Research, The Affiliated Stomatological Hospital of Kunming Medical University, Kunming, 650106, Yunnan, China.
Yanghao Wang *Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China.
Jianguo Xu *Department of Dental Research, The Affiliated Stomatological Hospital of Kunming Medical University, Kunming, 650106, Yunnan, China.
Rongqiang YangDepartment of Dental Research, The Affiliated Stomatological Hospital of Kunming Medical University, Kunming, 650106, Yunnan, China.
Weizhou WangDepartment of Orthopaedics, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China.
Xiaofang WangDepartment of Pathology, The Second Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China.
Xue CaoDepartment of Laboratory Animal Science, Kunming Medical University, Kunming, 650500, Yunnan, China.
Yiting LiDepartment of Dental Research, The Affiliated Stomatological Hospital of Kunming Medical University, Kunming, 650106, Yunnan, China.
Lifu YuDepartment of Dental Research, The Affiliated Stomatological Hospital of Kunming Medical University, Kunming, 650106, Yunnan, China.
Weihong WangDepartment of Oral and Maxillofacial Surgery, The Affiliated Stomatological Hospital of Kunming Medical University, Kunming, 650106, Yunnan, China.
Yanan ShiDepartment of Dental Research, The Affiliated Stomatological Hospital of Kunming Medical University, Kunming, 650106, Yunnan, China.
Changbin ZhangDepartment of Oral and Maxillofacial Surgery, The Affiliated Stomatological Hospital of Kunming Medical University, Kunming, 650106, Yunnan, China.
Hefeng YangDepartment of Dental Research, The Affiliated Stomatological Hospital of Kunming Medical University, Kunming, 650106, Yunnan, China. yanghefeng2008@163.com.
Yongwen HeDepartment of Dental Research, The Affiliated Stomatological Hospital of Kunming Medical University, Kunming, 650106, Yunnan, China. heyongwen2@sina.com.
Li BianDepartment of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China. bianli@kmmu.edu.cn.
Kunming Medical University · CN

Funding

the Regional Fund Project of the National Natural Science Foundation of China 82060423the Regional Fund Project of the National Natural Science Foundation of China 82060496Yunnan Provincial Department of science, Technology-Kunming Medical University applied basic research joint special major project 202001AY0700 1-007Yunnan Provincial Education Department Scientific Research Fund 2023Y0786
6 · The paper itself

Abstract

aimsThis study aims to explore the role of exosomes from cancer-associated fibroblasts (CAFs) induced by PDGF-BB in promoting the malignancy of oral squamous cell carcinoma (OSCC) and provide new insight into the mechanism of OSCC progression and its treatment. MAIN

methodsExosomes were extracted from human oral mucosa fibroblasts (hOMFs) and CAFs. Differentially expressed miRNAs of exosomes between hOMFs and CAFs were analysed using high-throughput sequencing and self-programmed R software. Cal-27, a human tongue squamous carcinoma cell line, was treated with exosomes. Differentially expressed miRNAs between clinical cancer tissues and adjacent tissues and between hOMF and CAF exosomes were verified by qRT‒PCR. The effect of miR-3529-3p on Cal-27 cells was clarified by overexpressing or knocking down miR-3529-3p in Cal-27 cells. Sample expression and differentially expressed miRNA expression were compared between cancer and paracarcinoma tissues. KEY

findingsWe found that exosomes from CAFs (CAF-Exos) were internalized by tongue squamous carcinoma cells and promoted their proliferation, migration, invasion, and antiapoptotic effects. MiR-3529-3p was a significant differentially expressed miRNA between CAF-Exos and exosomes from hOMFs (hOMF-Exos). The overexpression of miR-3529-3p promoted proliferation, migration, and invasion and inhibited apoptosis of Cal-27 cells. SIGNIFICANCE: This study explores the role of PDGF-BB-induced CAFs in promoting malignancy in OSCC. This study will provide new insight into the mechanism of OSCC progression and its treatment.

Indexed as

Cancer-associated fibroblastsExosomesmiR-3529-3pOSCCPDGF-BB

Identifiers

PMID37668846
PMCPMC10480386
OpenAlexW4386438691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.